Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/D000077597
http://purl.bioontology.org/ontology/MESH/D000077597
|
|---|---|
| Preferred Name | Vildagliptin |
| Definitions |
A pyrrolidine-carbonitrile derivative and potent inhibitor of DIPEPTIDYL PEPTIDASE 4 that is used in the treatment of TYPE 2 DIABETES MELLITUS.
|
| Synonyms |
NVP LAF237
(2S)-(((3-Hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile
Galvus
NVP-LAF237
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A pyrrolidine-carbonitrile derivative and potent inhibitor of DIPEPTIDYL PEPTIDASE 4 that is used in the treatment of TYPE 2 DIABETES MELLITUS. |
|---|---|
| altLabel |
NVP LAF237
(2S)-(((3-Hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile
Galvus
NVP-LAF237
|
| prefLabel | Vildagliptin
|
| Machine permutation | 2019; VILDAGLIPTIN was indexed under NITRILES and PYRROLIDINES 2005-2018
|
| HN | 2019 (2005)
|
| Mapped from | |
| type | |
| isa | |
| PA |
D054873
D007004
|
| tui |
T109
T121
|
| TERMUI |
T675814
T000940431
T000940430
T645791
|
| TH |
NLM (2005)
FDA SRS (2013)
USAN (19XX)
INN (19XX)
NLM (2006)
|
| MMR | 20190101
|
| notation | D000077597
|
| Semantic type UMLS property | |
| Inverse of AQ |
See more
See less
|
| DX | 20190101
|
| cui |
C1570906
C1570909
C1721378
|
| DC | 1
|
| MN |
D02.626.943
D03.383.773.953
|
| LT | TRD
|
| AQL | AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
| Inverse of RB |
I6B4B2U96P
0
|
| MDA | 20180214
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |